Motif Bio PLC - AIM cash shell - Says it is currently advancing the necessary work streams to complete the reverse takeover process with a UK-based candidate in the healthcare sector. Notes it expects to provide shareholders with a further update during the second half of January. Motif Bio is expected to make a reverse takeover acquisition by January 28. Failure to do so may result in its admission on the AIM market of the London Stock Exchange being cancelled.
Current stock price: Shares suspended from trading on July 29, 2020
By Ife Taiwo; ifetaiwo@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.